LIMN   $0.1137  10.39% Market Open

Liminatus Pharma, Inc.

EMA (20): 2026-07-17 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2026-02-11 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2026-02-10 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

Trend Type down and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -7.56%
EMA (20) date of signal July 17, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -80.96%
EMA (50) date of signal Feb. 11, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -90.98%
EMA (100) date of signal Feb. 10, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 10.39%
RSI (14) date of signal July 31, 2026, 3 a.m.
MACD Signals bearish weakening
MACD Yield 0.0
MACD date of signal Aug. 3, 2026, 3 a.m.
Stochastic Signals bearish weakening
Stochastic Yield 11.36%
Stochastic date of signal July 30, 2026, 3 a.m.
Updated Aug. 4, 2026, 11:01 p.m.